We demonstrated wide-ranging expression of PRAME mRNA and protein across melanoma subtypes, gynecologic cancers (ovarian and endometrial), lung (SCLC and NSCLC), and TNBC, consistent with previous reports [5, 35]. Here, PRAME is linked to female reproductive organ cancer.